NASDAQ Companies

– 10,000-subject Phase 2b study would evaluate Vaxart’s next generation oral pill XBB COVID-19 vaccine against an approved mRNA vaccine […]

LIMASSOL, Cyprus, Jan. 19, 2024 (GLOBE NEWSWIRE) — GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or […]

NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors […]

JACKSONVILLE, Fla., Jan. 19, 2024 (GLOBE NEWSWIRE) — Regency Centers Corporation (The “Company”) (Nasdaq:REG) today announced the federal income tax […]

“King of the Internet” Dave Portnoy’s Uber-Popular Sports Media Company to Spotlight FDA-Approved Oral Testosterone Replacement ‘Prime’ by MangoRx, Powered […]

AUSTIN, Texas, Jan. 19, 2024 (GLOBE NEWSWIRE) — Phunware, Inc. (Nasdaq: PHUN, “Phunware”), the pioneer of patented Location Based SaaS […]

LOS ALAMITOS, Calif. and LAS VEGAS, Jan. 19, 2024 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or […]

EMERYVILLE, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) — NMI Holdings, Inc. (Nasdaq: NMIH) today announced that Fitch Ratings has assigned […]

San Diego, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) — Southern California Bancorp (“us,” “we,” “our,” or the “Company”) (NASDAQ: BCAL), […]

FDA and Processa agree to expand NGC-Cap development into breast cancer providing a more efficient path to approval FDA agrees […]